Clinical Library · Women's Health
Inositol for PCOS: The 40:1 Myo:D-Chiro Ratio Explained
One in five Indian women lives with PCOS — irregular cycles, stubborn weight, acne, sugar cravings, low mood. The single most-studied nutrient for it isn't a vitamin or an herb. It's a B-vitamin-like sugar alcohol called inositol — specifically the 40:1 ratio of myo-inositol to D-chiro-inositol. Here's why that exact ratio matters, what it does inside the ovary, and how to take it.
What inositol actually does
Inositol is a second-messenger inside cells — it relays the insulin signal from the cell surface to the machinery that handles glucose. There are nine natural isomers, but two matter for PCOS:
- Myo-inositol (MI) dominates in the brain, ovaries and follicular fluid. It controls FSH signalling and egg quality.
- D-chiro-inositol (DCI) dominates in the liver, fat and muscle. It handles glucose disposal and androgen synthesis.
Your body interconverts MI to DCI on demand using an insulin-driven enzyme (epimerase). In a healthy ovary the ratio sits at ~100:1 in favour of MI; in healthy plasma it's ~40:1. PCOS disrupts this — the ovary suddenly over-converts MI to DCI, robbing the follicle of the MI it needs for FSH and raising DCI to androgen-driving levels. This is called the "DCI paradox" and it's the mechanistic root of most PCOS symptoms.
Why the 40:1 ratio is the gold standard
Early PCOS supplements used DCI alone or 2:1 ratios. Results were mixed — and high-DCI arms actually worsened egg quality. The breakthrough came from Italian researchers (Nordio, Unfer and colleagues) who showed that supplementing the physiological plasma ratio — 40 parts myo-inositol to 1 part D-chiro-inositol — restored normal ovarian function in 3 months, outperformed every other tested ratio, and is the protocol now used in the international PCOS treatment guidelines.
| Ratio MI:DCI | Outcome in clinical trials |
|---|---|
| DCI alone | Worsened oocyte quality, lower fertilisation |
| 2:1 | Poor ovulation response |
| 5:1 | Partial improvement |
| 20:1 | Approaching physiological |
| 40:1 (Plasma) | Best ovulation, insulin, androgen, AMH |
| 80:1 | Diminishing returns |
Sources: Nordio M, Proietti E. Eur Rev Med Pharmacol Sci 2012; Unfer V. et al. Int J Endocrinol 2016; Monash International PCOS Guideline 2023.
What the research shows — symptom by symptom
Cycle regularity & ovulation
70–80% of women restore ovulation within 3 months
Confirmed across multiple RCTs at 4 g MI + 100 mg DCI/day. Often the first symptom to shift.
Insulin sensitivity & weight
Lower fasting insulin, smaller waist, fewer cravings
Inositol acts on the same insulin pathway as metformin but without lactic-acid or GI risk.
Androgens, acne, hair
Free testosterone drops ~30% in 12 weeks
Less jawline acne, less mid-cycle breakouts, slower facial hair growth (give 4–6 months).
Egg quality & fertility
Better oocyte maturation in IVF cycles
Used routinely in fertility clinics 3 months before retrieval to improve egg quality.
Mood & anxiety
Inositol modulates serotonin and GABA pathways
Trials show benefit for PMDD, panic disorder and PCOS-linked low mood at similar doses.
Inositol vs metformin
Metformin was the default insulin-sensitiser for PCOS for two decades. Head-to-head trials (Fruzzetti 2017, Le Donne 2019, Facchinetti meta-analysis 2020) show inositol 40:1 matches metformin on every metabolic and ovulatory endpoint — with a fraction of the gut side-effects, no B12 depletion and no lactic-acid risk. The 2023 Monash International PCOS Guideline now lists inositol as an evidence-based first-line option. Many women combine the two in lower doses with their doctor.
Dosage, timing, and what to expect
The protocol used in essentially every successful trial is 2,000 mg myo-inositol + 50 mg D-chiro-inositol, twice daily (4 g + 100 mg total). Take it with meals — breakfast and dinner is the easiest split. Powder mixes into water with a mild sweet taste; capsules work equally well.
| Timeline | What typically shifts |
|---|---|
| Week 2–4 | Cravings, energy, sleep, PMS |
| Week 4–8 | Skin clarity, insulin/HOMA-IR improves |
| Month 3 | Cycle regularity, ovulation returns |
| Month 4–6 | Androgens, AMH, fertility markers |
What pairs well with inositol
- Quatrefolic® L-5-MTHF (active folate). Up to 50% of Indian women carry an MTHFR variant. The methylated form bypasses it.
- Chromium picolinate. Synergistic with inositol on glucose disposal.
- Strength training 2–3×/week. Builds muscle (the body's glucose sink) and lowers androgens better than cardio alone.
Ova Balance — 40:1 inositol, done right
Ova Balance delivers the clinical 40:1 ratio — 2,000 mg myo-inositol + 50 mg D-chiro-inositol per serving — alongside Quatrefolic® L-5-MTHF folate and chromium picolinate. No glutathione, no random fillers — just the stack the Monash 2023 guidelines actually recommend.
FAQs
Can I take inositol if I'm trying to conceive?
Yes — it's used routinely in fertility protocols. Add active folate (L-5-MTHF 400 mcg) and check with your doctor if you're on other medication.
Are there side effects?
Very rare. Mild nausea at doses above 12 g/day. The 4 g + 100 mg protocol is exceptionally well tolerated — that's a big part of why it's outperforming metformin in clinics.
Do I need to take it forever?
Most clinicians recommend 6–12 months as a re-set, then re-assess. Many women continue at half-dose for cycle and mood maintenance.
Will inositol help if I don't have PCOS?
It can. It's studied for PMDD, anxiety, gestational diabetes prevention and metabolic syndrome. The 40:1 dose is fine for general insulin/mood support too.
References
Every in-text claim in this article is credited to the original researchers and peer-reviewed journal below. Key studies cited: Unfer V et al. (2017, Endocrine Connections); Nordio M et al. (2012, European Review for Medical and Pharmacological Sciences); Facchinetti F et al. (2015, European Journal of Obstetrics & Gynecology and Reproductive Biology).
- [1]
Myo-inositol effects in women with PCOS: a meta-analysis of randomized controlled trials
- Author(s)
- Unfer V, Facchinetti F, Orrù B, Giordani B, Nestler J
- Year
- 2017
- Journal
- Endocrine Connections
- Citation
- Unfer V, Facchinetti F, Orrù B, Giordani B, Nestler J. Myo-inositol effects in women with PCOS: a meta-analysis of randomized controlled trials. Endocr Connect. 2017;6(8):647–658.
- PubMed
- https://pubmed.ncbi.nlm.nih.gov/29042448/
- [2]
The combined therapy with myo-inositol and D-chiro-inositol reduces the risk of metabolic disease in PCOS overweight patients compared to myo-inositol supplementation alone
- Author(s)
- Nordio M, Proietti E
- Year
- 2012
- Journal
- European Review for Medical and Pharmacological Sciences
- Citation
- Nordio M, Proietti E. The combined therapy with myo-inositol and D-chiro-inositol reduces the risk of metabolic disease in PCOS overweight patients compared to myo-inositol supplementation alone. Eur Rev Med Pharmacol Sci. 2012;16(5):575–581.
- PubMed
- https://pubmed.ncbi.nlm.nih.gov/22774396/
- [3]
Results from the International Consensus Conference on myo-inositol and d-chiro-inositol in obstetrics and gynecology
- Author(s)
- Facchinetti F, Bizzarri M, Benvenga S, D'Anna R, Lanzone A, Soulage C, et al.
- Year
- 2015
- Journal
- European Journal of Obstetrics & Gynecology and Reproductive Biology
- Citation
- Facchinetti F, Bizzarri M, Benvenga S, et al. Results from the International Consensus Conference on myo-inositol and d-chiro-inositol in obstetrics and gynecology. Eur J Obstet Gynecol Reprod Biol. 2015;195:72–76.
- PubMed
- https://pubmed.ncbi.nlm.nih.gov/26479442/
Citations follow AMA format. TruWe does not own or endorse the linked journals; all rights and credit remain with the original authors and their respective publishers.
This article is for general education only and is not a substitute for medical advice. Consult a qualified clinician before starting any supplement, especially if you take medication, are pregnant, or have a thyroid or kidney condition.
